Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026
Same author

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.

ESMO open·2024
Same author

Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

Radiotherapy for patient with cardiac implantable electronic device, consensus from French radiation oncology society.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

Radiation therapy of pancreatic cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021

Related Experiment Video

Updated: Mar 16, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

[Radiotherapy for primary lung carcinoma].

P Giraud1, T Lacornerie2, F Mornex3

  • 1Service d'oncologie radiothérapie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université Paris-Descartes, Paris-Cité Sorbonne, 12, rue de l'École-de-Médecine, 75006 Paris, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|August 13, 2016
PubMed
Summary

This study details radiotherapy and chemotherapy for primary lung carcinoma, including target volume and organ delineation. It provides essential guidance for treating lung cancer patients.

Keywords:
Asservissement respiratoireCancer du poumonChemoradiotherapyChimioradiothérapieLung carcinomaRadiotherapyRadiothérapieRadiothérapie stéréotaxiqueRespiratory gatingStereotactic radiotherapy

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K

Related Experiment Videos

Last Updated: Mar 16, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Primary lung carcinoma presents complex treatment challenges.
  • Optimizing radiotherapy and chemotherapy requires precise technical guidelines.
  • Accurate delineation of target volumes and organs at risk is critical for effective treatment and minimizing toxicity.

Purpose of the Study:

  • To present comprehensive recommendations for the indication, dosage, and technique of radiotherapy for primary lung carcinoma.
  • To detail the use of concomitant chemotherapy alongside radiotherapy.
  • To provide specific guidance on delineating target volumes and organs at risk in lung cancer radiotherapy.

Main Methods:

  • Review and synthesis of current evidence-based guidelines for lung cancer treatment.
  • Detailed description of radiotherapy planning and delivery techniques.
  • Elaboration on chemotherapy regimens used concurrently with radiation therapy.

Main Results:

  • Specific indications and recommended doses for radiotherapy are presented.
  • Techniques for radiotherapy delivery, including target volume and organ at risk delineation, are detailed.
  • Guidelines for concomitant chemotherapy administration are provided.

Conclusions:

  • The presented recommendations aim to standardize and optimize the treatment of primary lung carcinoma.
  • Adherence to detailed target volume and organ at risk delineation is crucial for treatment efficacy and patient safety.
  • This guidance supports clinicians in delivering high-quality radiotherapy and chemoradiotherapy for lung cancer.